aTyr Pharma, Inc. (ATYR) stock news · rev $190.0K
aTyr Pharma, Inc. (ATYR) is a biotechnology company listed on US.
This ATYR news page leads with what aTyr Pharma, Inc. filed — not a scraped headline mill.
No cached 8-K sentence for ATYR yet. We will not pad this page with generic market recap.
Latest reported ATYR revenue for 2025-12-31 was $190.0K. Net income was -$74.1M. Revenue was down 19.1% from 2024-12-31 to 2025-12-31. ATYR currently screens at market cap $471.7M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ATYR stock page; for the tape open the quote page.
ATYR stock news FAQ
What are ATYR's latest revenue and net income?
Latest cached aTyr Pharma, Inc. (ATYR) revenue for Dec 31, 2025 was $190.0K. Net income was -$74.1M. Statements: https://lician.com/financials/atyr
How did ATYR revenue change from the prior cached period?
Cached aTyr Pharma, Inc. (ATYR) revenue was down 19.1% from $235.0K (Dec 31, 2024) to $190.0K (Dec 31, 2025). Statements: https://lician.com/financials/atyr
What is ATYR's market cap?
aTyr Pharma, Inc. (ATYR) market cap is $471.7M on the latest cached fundamentals snapshot.
What kind of company is ATYR?
aTyr Pharma, Inc. (ATYR) is a biotechnology company listed on US.
Where is ATYR stock news listed?
Cached stock news for aTyr Pharma, Inc. (ATYR) is listed at https://lician.com/news/atyr. Filings: https://lician.com/sec/atyr
Not investment advice.